X4 Pharmaceuticals

X4 Pharmaceuticals is a biotechnology company driven by a mission to empower people with rare immune disorders. We leverage innovative science and compassionate care to develop and commercialize transformative therapies that address significant unmet needs in this underserved patient population.

Our Commitment to Progress

Our dedicated team of scientists, researchers, and healthcare professionals are committed to:

• Delivering progress: We are driven by a deep understanding of the challenges faced by patients and their families.
• Advancing innovation: We continuously explore emerging science and technologies to deliver novel therapeutic solutions.
• Patient-centric approach: We prioritize patient safety and efficacy throughout the development and commercialization of our therapies.

Areas of Expertise

Our expertise spans various key areas:

• R&D: Experienced researchers with deep understanding of CXCR4 biology and immune system targeted therapies.
• Commercialization: Proven track record in bringing innovative products to market.
• Manufacturing: Collaborations with leading manufacturing partners ensure quality and efficacy.
• Clinical development: Expertise in executing and managing clinical trials.

X4 Pharmaceuticals: Making a Difference

Through the development and commercialization of mavorixafor, we have already made a significant impact on the lives of patients with rare immune disorders. Our unwavering commitment to innovation and collaboration positions us to address the diverse needs of this population and bring hope to those who suffer.